As of August 28, 2026, CRISPR Therapeutics AG (CRSP) has a DilutionWatch DilutionScore of 15/100, rated LOW dilution risk. CRISPR Therapeutics AG has a market capitalization of $5.42B, 96.69M shares outstanding, 501 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CRSP.
Market Data
Market Cap$5.42B
Shares Outstanding96.69M
Float96.04M
Cash$2.36B
Debt$586.20M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 6.4% shares (2026Q1 vs prior)
501 institutional holders · 91.81M shares
#1
ARK Investment Management LLC
11.31M shares
#2
BlackRock, Inc.
7.68M shares
#3
Orbis Allan Gray Ltd
6.11M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest18.82M
Days to Cover11.5
% of Float19.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2016-12-31
4
INSIDER TRANSACTION
2026-03-24
4
INSIDER TRANSACTION
2026-03-24
4
INSIDER TRANSACTION
2026-03-24
4
INSIDER TRANSACTION
2026-03-24
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CRSP Dilution Snapshot
CRISPR Therapeutics AG (CRSP) has a DilutionScore of 15/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CRSP: 4 on 2026-03-24; 4 on 2026-03-24; 4 on 2026-03-24.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CRSP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRSP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CRSP
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.